3SOF

No reason why not. Improving cash and revenue flow. Way undervalued.

I think we need a chart here so we know what she looks like....

Press Release Source: Linkwell Corporation


Linkwell Corporation Assumes Management and Operational Control of Gene Diagnostics Company in Beijing
Monday December 18, 8:00 am ET


SHANGHAI, CHINA--(MARKET WIRE)--Dec 18, 2006 -- Linkwell Corporation (OTC BB:LWLL.OB - News), a leading developer, manufacturer and distributor of healthcare-related disinfectants in China, today announced its Chinese subsidiary, Likang Disinfectant High-Tech Company, Limited, has entered into an agreement to assume management and operational control of Zhongke Jinmeihua Biotech Company, Limited ("Jinmeihua"). The contractual arrangements include exclusive sales, consulting, and operating agreements. Additionally, Linkwell has the option to acquire Jinmeihua by December 31, 2007, on the basis of net tangible assets.
Zhongke Jinmeihua, founded in May 2006 as a national certified high-tech enterprise, engages in providing services of gene diagnostics for early detection of human diseases, such as tumors, cardiovascular diseases, diabetes, and genetic disorders. For more information about Jinmeihua, please visit http://www.zkjmh.com

ADVERTISEMENT


The Company had unaudited revenues from operations of approximately $750,000 in the quarter ending September 30, 2006, with approximately 15% net profit margin. Under the contractual arrangements, Linkwell will be able to consolidate the financial statements of Zhongke Jinmeihua under the GAAP accounting principles.

A rapidly expanding number of genetic mechanisms contributing to disease can be accessed via molecular analysis. In order to take full advantage of this potential for genetic diagnostics, and to monitor treatment by gene therapy and other emerging methods, a new generation of diagnostic techniques will be required. Of central importance in future analyses is the possibility to perform very large numbers of simultaneous genetic analyses in analytical devices of small linear dimensions. Scientists have developed a new molecular probe design that is amenable to highly multiplex, specific analyses of total genomic DNA or of RNA molecules expressed in tissue samples. Jinmeihua's technology platform is supported by Beijing Gene Research Laboratory of Chinese Academy of Science. With advanced Gene-Sequencing Technology and SNP Genotyping Technology, Beijing Gene Research Laboratory is ranked as one of top molecular genetics laboratories in the world.

Mr. Xuelian Bian, CEO and President of Linkwell Corp., stated, "Gene diagnostics is the cutting edge technology in the latest g advance of molecular genetics. This agreement is an important step in management's objective to broaden its sales offerings and leverage its distribution channels. We will utilize our marketing capabilities to expand Jinmeihua's sales significantly in 2007. By using different resources such as local hospitals, sales networks, professional conferences, management is confident that Linkwell can significantly increase sales for this high margin product category with its current sales team and sees this agreement providing Linkwell with a significant increase in revenue and operating income in 2007 and beyond. We believe this new division will substantially enhance our prospective of triple-digit growth of revenues and earnings for 2006 to 2008."

Interesting presentation:

http://china.seekingalpha.com/article/20674

10K due tomorrow.

May 21, 2007 - 7:30 AM EDT           


Linkwell Corporation Reports Record Revenues of $2,845,832 and EPS of $.01 for the First Quarter of 2007
Revenues up 52% and Earnings up 145% From the Same Period in 2006
Linkwell Corporation (OTCBB: LWLL), a leading developer, manufacturer and distributor of healthcare related disinfectants in China, today announced its financial results for the first quarter ended March 31, 2007.

The Company recorded record revenues of $2,845,832 for the first quarter ended March 31, 2007, representing an approximately 52% increase from the $1,868,526 recorded in the first quarter of 2006. Gross profit for the first quarter ended March 31, 2007 was $992,712, representing an approximately 55% increase from gross profit of $641,078 in the first quarter of 2006. Net income for the first quarter of 2007 was $496,571 or $0.01 earnings per share, representing an approximately 145% increase from net income of $201,940 or $0.00 for the same period of 2006.

As of March 31, 2007, the total assets increased to $7,874,090 as compared to $6,944,492 at December 31, 2006. Shareholder equity as of March 31, 2007 increased by 24% to $4,887,941, up from $3,944,898 as of December 31, 2006.

For more details about Linkwell's financial performance, please review the 10-QSB filed with the United States Securities and Exchange Commission.

Linkwell's Chairman and CEO, Xuelian Bian stated, "We are pleased that our sales efforts and marketing plan have achieved these record results for our shareholders. Moving through the rest of 2007, we intend to continue to develop and market our leading brands as well as further expand our channels of distribution. We continue to actively seek strategic partnerships with multinational companies to leverage our resources and distribution capabilities and anticipate near term success in our efforts. Our management team continues to identify further areas for cost savings throughout our business, and we continue to pursue acquisitions that will extend our distribution network or complement our current business. We are committed to maintaining our leadership status as an innovator in the healthcare related disinfectant industry in China. We believe our initiatives in 2007 will continue to enhance our performance and expand our presence in the marketplace. Our results only add to our commitment to do better and exploit our current opportunities and we will continue to work aggressively to maximize our financial performance for our shareholders. We anticipate 2007 to be our best performing year to date as we continue to see strong momentum in our sales pipeline."

Time to buy.

Clicked off the bottom. 52 week low with a $0.50 upside and no downside risk.

Positive EPS.

China floods ETC.

BERLIN, June 24 (Reuters) - The deadly strain of the bird flu virus has resurfaced in Germany in the bodies of at least three dead birds found in the state of Bavaria, Germany's first confirmed cases this year, officials said on Sunday.

The corpses of several more birds found in the southern state are being analysed to see if they also contain the deadliest strain of the H5N1 virus, a spokeswoman for the Bavarian city of Nuremberg said.

The country's top veterinary laboratory, the Friedrich Loeffler Institute, confirmed that three wild birds -- two swans and a goose -- found in two lakes near Nuremberg had tested positive for the worst strain of the H5N1 virus.

"Over the next few days the city of Nuremberg will be supported by a federal epidemiological team which will scientifically investigate the causes and background of the infection cases," the city of Nuremberg said in a statement.

It said that poultry farmers in the region were required to confine all poultry birds to closed stalls. It added that as of Saturday a 21-day ban had been imposed on bringing poultry birds or products in or out of the area, now a quarantine zone.

City officials also warned cat and dog owners not to allow their pets to roam freely in the quarantine zone.

Germany quickly passed this information on to the European Commission.

"Highly pathogenic avian influenza H5N1 was detected in more than 700 wild birds in the EU in 2006," the Commission said in a statement. It added that the infected swans in Bavaria were the European Union's first cases reported in wild birds in 2007.

DEAD BIRDS

Five other dead birds found near Nuremberg tested positive for the H5N1 virus but it remains unclear whether they have the deadly Asian strain, German officials said.

In addition to the dead swans and goose, the body of at least one wild duck has been confirmed to have some form of the H5N1 virus, Nuremberg city said.

The Friedrich Loeffler Institute is carrying out tests on the animals to determine which H5N1 strain they carried.

Last year, some 13 European Union member states had confirmed cases of bird flu -- Germany, Austria, Denmark, Italy, Greece, Britain, the Czech Republic, Poland, Slovakia, Slovenia, Sweden, France and Hungary.

Czech veterinarians started culling several thousand turkeys on a farm last week after tests confirmed the country's first outbreak of a deadly form of bird flu in poultry.

Bird flu has been spreading across southeast Asia, killing two people in Vietnam this month, the first deaths there since 2005.

Globally, the H5N1 virus has killed nearly 200 people out of over 300 known cases, according to the World Health Organisation. None of the victims were from Europe.

Hundreds of millions of birds have died or been slaughtered. (Additional reporting by Holger Hansen in Berlin and Jeff Mason in Brussels)

You got to track your stock picks if you plan on making any money.......
Yesterday's closing chart.